AD-519 neutralizing monoclonal antibody directed against the C4 region of gp120 envelope glycoprotein of HIV: Began an open-label Phase I/IIa trial under an inv

Tanox Biosystems Inc., Houston
Product: AD-519

Read the full 67 word article

How to gain access

Continue reading with a
two-week free trial.